Facts and figures

HeadquarterDenmark
InternationalInternational production facilities in seven countries.
Affiliates or offices in 75 countries.
WorkforceApproximately 40,700 employees (September 2014).
Approximately 42% of employees are located in Denmark (17,202) and 58% in the rest of the world (North America: 6,533, Japan & Korea: 1,083, China: 5,045, International Operations: 6,492, Europe: 4,361).
18% within research and development
29% in production and production administration
36% in international sales and marketing
17% in administration
Product areas We have four product areas:
Diabetes care 
Haemostasis management
Growth hormone therapy 
Hormone replacement therapy

According to applicable law, only health care professionals are allowed to access the product information on our site. You can find the information under 'Health Care Processionals' in the top menu. For patient and disease information, look under 'Patients'. 
Q3 sales*22,249
Annual sales**83,572 (See Annual Report for more information)
Sales by business segment* Diabetes care 17,688
Biopharmaceuticals 4,561
Sales by region* Europe 5,045
North America 11,133
International Operations 2,938
China 1,881
Japan & Korea 1,252

Notes
* million Danish kroner, Q3 results 2014
** million Danish kroner, full year results 2013

Novo Nordisk A/S
Bagsværd, Denmark, 
CVR nr. 24 25 67 90

  •  


  •  
  •  

Share information

Learn more about Novo Nordisk shares.

Shareholder rights


  •  
  •  

Novo Nordisk products

Facts about Novo Nordisk products

Product facts

  •